The global intermittent catheters market size was estimated at USD 2.1 billion in 2024 and is projected to grow at a CAGR of 6.11% from 2025 to 2030. Growth in the market can be attributed to the rising prevalence of urinary incontinence and neurogenic bladder disorders, particularly among the geriatric population.
Increased awareness of the benefits of intermittent catheterization over indwelling catheters, such as reduced risk of infection and greater patient comfort, also contributes to market expansion. In addition, technological advancements in catheter design, including hydrophilic coatings and single-use options that enhance patient convenience and hygiene, drive adoption.
The increasing incidence of urinary incontinence, particularly among the geriatric population, drives the intermittent catheters market. Age-related factors such as weakened bladder muscles, hormonal changes, and comorbidities such as diabetes contribute to this condition. For instance, in August 2024, the European Medical Journal cited that there is a notable rise in overactive bladder (OAB) cases among men, with prevalence increasing from 11.3% in 2005-2008 to 14.5% in 2015-2020, especially among non-Hispanic White and Black men aged 40-59. Such factors are expected to drive the market.
Technological advancements in this field are expected to further drive the growth of the intermittent catheter market. For instance, in 2024, Convatec, a global medical products and technologies company, introduced new resources to support intermittent catheter users, including an interactive video and the me+ Companion app, which allows users to log beverage and urine intake, providing educational tools and support at their fingertips. These developments improve the user experience and encourage adherence to catheterization routines, thereby expanding the market.
The coated segment held the largest market share in 2024 and is anticipated to witness the fastest growth rate over the forecast period, owing to the benefits of coated intermittent catheters, particularly hydrophilic and antimicrobial variants. The coated intermittent catheters reduce friction during insertion and removal, minimizing urethral trauma and enhancing patient comfort. Such features are beneficial for those individuals who require regular catheterization, such as those with urinary incontinence or spinal cord injuries. In addition, the coatings help reduce the risk of urinary tract infections (UTIs), a common complication associated with catheter use. For instance, in January 2025, ScienceDirect cited in its article that hydrophilic-coated catheters have been shown to lower the incidence of UTIs compared to uncoated catheters, contributing to their increased adoption.
The non-coated segment is also growing significantly over the forecast period. This is attributed to factors such as the cost-effectiveness of non-coated intermittent catheters, making them an accessible option for healthcare systems with budget constraints and patients without comprehensive insurance coverage. In addition, non-coated catheters offer greater flexibility in lubrication choices, allowing users to select lubricants that best suit their needs and preferences. For instance, in regions with limited access to advanced medical supplies, non-coated catheters provide a practical solution for patients requiring intermittent catheterization.
The offline segment held the largest market in 2024 and is expected to witness the fastest growth rate over the forecast period. This growth is mainly due to offline channels, such as hospitals, clinics, and pharmacies, which plays an important role in giving quick access to intermittent catheters, especially in urgent care situations where fast action is needed. In these places, healthcare workers give personal help, making sure patients choose the right catheter and know how to use it correctly. This is especially helpful for geriatric patients or those with long-term health problems who need to use catheters regularly. Moreover, offline channels facilitate better inventory management and immediate product availability, crucial for medical supplies such as catheters that are essential for daily patient care. These factors collectively contribute to the sustained growth and preference for offline distribution channels in the intermittent catheters market.
The online segment is expected to grow at the fastest CAGR during the forecast period. This growth is mainly because more people now prefer the ease and convenience of buying medical supplies online. With more e-commerce platforms available, patients, especially those with long-term health issues who need to use catheters regularly, can now easily get the products they need without having to go to physical stores often.
The hospital segment held the largest market share in 2024 and is expected to grow at the fastest CAGR over the forecast period. This is because hospitals are equipped with advanced medical infrastructure and skilled healthcare professionals, enabling them to perform complex procedures and provide comprehensive care. In addition, favorable reimbursement policies in many regions encourage patients to seek treatment in hospitals, further driving the demand for intermittent catheters. Moreover, the increasing number of surgical procedures performed in hospitals, which often require catheterization during or post-operation, contributes to the segment's growth. The integration of technologically advanced catheterization techniques and the availability of a wide range of catheter products in hospitals also significantly attract patients to these facilities. These factors are propelling growth of the hospital segment in the intermittent catheters market.
The ambulatory surgery center (ASC) segment is anticipated to grow at the fastest CAGR during the forecast period, driven by several key factors such as ASCs offer a cost-effective alternative to traditional hospital settings, providing outpatient surgical services with reduced overhead costs and increased operational efficiency. ASCs can now perform a wider range of procedures because of innovation in medical technology, including higher-acuity surgeries such as joint replacements and cardiovascular interventions. In addition, changes in state regulations, such as the loosening of Certificate of Need (CON) laws, have further fueled the expansion of ASCs, allowing for increased access to these facilities. The growing preference for minimally invasive procedures, shorter recovery times, and the convenience of same-day surgeries further contribute to the rapid growth of the ASC segment in the intermittent catheters market.
In North America, the rising demand for intermittent catheters is due to improving healthcare systems and growing awareness of urological health. In Canada, universal healthcare and a focus on home care services make it easier for patients with spinal cord injuries, multiple sclerosis, and other chronic conditions to access catheter products. Mexico has been expanding its public healthcare coverage, and efforts are being made to improve access in underserved areas. As chronic disease rates rise and patient education improves, demand for discreet, safe, and easy-to-use intermittent catheters is increasing steadily.
In U.S., the demand for intermittent catheters is high due to the geriatric population, increased prevalence of chronic conditions, and a well-established healthcare system. In the United States, conditions like spinal cord injuries, diabetes, and multiple sclerosis contribute significantly to the need for urinary catheterization. For instance, in October 2024, the U.S. Centers for Disease Control and Prevention reports that 6 in 10 Americans live with a chronic disease, many of which can lead to urinary dysfunction. In addition, health insurance coverage and growing awareness of home-based healthcare options support consistent market growth in this region.
In Europe, there is a strong demand for intermittent catheters, supported by advanced healthcare systems and favorable reimbursement policies. Geriatric populations, especially in countries like Italy and Germany, are leading to more cases of urinary incontinence and neurogenic bladder. Public health insurance covers urological products, making them more accessible. Moreover, early diagnosis and physician-driven patient education in these countries contribute to the widespread adoption of intermittent catheterization. In addition, technological innovations are also influencing buyer preferences and boosting market growth across continental Europe.
The UK intermittent catheters market is expected to grow rapidly in the coming years as this country has a large and growing geriatric population, which contributes to a rising incidence of health conditions such as urinary incontinence, neurogenic bladder, and prostate-related issues. These conditions often require long-term bladder management, increasing the demand for intermittent catheters. Chronic diseases such as diabetes and multiple sclerosis are also prevalent, further driving the need for urinary support solutions. There is a growing preference for self-managed care and home-based treatment, encouraging the adoption of discreet and user-friendly catheter products. Public awareness around hygiene, independence, and quality of life has also significantly promoted intermittent catheter use across the country.
The intermittent catheters market in Germany is growing significantly as it has a considerably aging population, which contributes to a higher incidence of age-related health conditions such as urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia. The demand for intermittent catheters is driven by the need to manage these conditions effectively. Germany’s public health insurance system ensures broad access to medical supplies, including catheters, at low or no out-of-pocket cost for most patients. In addition, the country has a high prevalence of chronic illnesses such as diabetes and multiple sclerosis, which often lead to bladder dysfunction. Clinical guidelines and a strong emphasis on home-based care further support the widespread use of intermittent catheterization.
The Asia Pacific region is experiencing rising demand for intermittent catheters due to rapid urbanization, population growth, and increasing incidences of diabetes and spinal cord injuries. Healthcare expenditure is rising, and infrastructure is improving in urban centers. Moreover, cultural stigmas and limited access in rural areas present challenges. Despite this, the market expands as awareness improves and disposable income rises. Local governments are also promoting self-care and hygiene through public health programs.
The China intermittent catheters market growth is attributed to the increase in the prevalence of chronic diseases such as diabetes, stroke, and spinal cord injuries among the rapidly growing elderly population. Improvements in healthcare infrastructure, particularly in urban areas, enhance access to diagnosis and treatment. The government is promoting home and community-based elder care services, supporting the use of medical devices such as intermittent catheters outside hospital settings. In addition, rising awareness around hygiene, self-care, and quality of life encourages more patients to adopt safer bladder management solutions.
In Latin America, the demand for intermittent catheters is supported by expanding access to healthcare and government-led health initiatives. Countries such as Brazil and Mexico are investing in public health infrastructure. The region is witnessing a rise in chronic conditions like diabetes and spinal injuries, which increases the need for catheterization. While healthcare access varies greatly between urban and rural populations, non-profit organizations and local governments are working to close this gap. Rising patient awareness and a gradual shift towards home care also contribute to market growth.
The Middle East and Africa (MEA) region has a growing interest in intermittent catheters, particularly in countries like Saudi Arabia and the UAE, where investments in hospital infrastructure and healthcare modernization are strong. Rising rates of chronic diseases, such as diabetes and stroke, are increasing the need for urinary care. In Africa, access remains limited due to economic and logistical barriers, but support from international health organizations and NGOs is gradually improving awareness and product availability.
The following are the leading companies in the intermittent catheters market. These companies collectively hold the major market share and dictate industry trends.
The following are the leading companies in the intermittent catheters market. These companies collectively hold the largest market share and dictate industry trends.
In June 2025, ConvaTec introduced the GentleCath Air, a compact intermittent catheter specifically designed for women. This innovative device incorporates FeelClean Technology, which activates upon removal from its case to provide a smooth, lubricated surface, facilitating easier insertion and removal.
In May 2024, Coloplast launched the Luja Female intermittent catheter, expanding its Luja portfolio to address female users' needs. This next-generation catheter features Micro-hole Zone Technology, incorporating over 50 micro-holes to facilitate complete bladder emptying in a single, uninterrupted flow, thereby reducing the risk of urinary tract infections (UTIs). Clinical studies demonstrated that 87% of users experienced zero flow stops, and 83% had less than 10 mL of residual urine at the first flow stop. In addition, users reported no discomfort during catheterization. The Luja™ Female catheter is designed sustainably, using 28% less plastic and a 22% lower carbon footprint than previous models.
Report Attribute |
Details |
Market size value in 2025 |
USD 2.24 billion |
Revenue forecast in 2030 |
USD 3.01 billion |
Growth rate |
CAGR of 6.11% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends, and product outlook |
Segments covered |
Product, distribution channel, end use, and region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; UK; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Hollister Incorporated; Teleflex Incorporated; Medline Industries, LP.; Cardinal Health; BD; Coloplast; ConvaTec |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the intermittent catheters market report based on product, distribution channel, end use, and region.
Product Outlook (Revenue, USD Million, 2018 - 2030)
Coated
Hydrophilic Coating
Gel Coating
Non Coated
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Online
Offline
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgery Center
Home Healthcare
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global intermittent catheters market size was estimated at USD 2.1 billion in 2024 and is expected to reach USD 2.24 billion in 2025.
b. The global intermittent catheters market is expected to grow at a compound annual growth rate of 6.11% from 2025 to 2030 to reach USD 3.01 billion by 2030.
b. North America dominated the intermittent catheters market with a share of 34.44% in 2024. This is attributable to its advanced healthcare infrastructure, high patient awareness, and robust reimbursement policies.
b. Some key players operating in the intermittent catheters market include Hollister Incorporated; Teleflex Incorporated; Medline Industries, LP.; Cardinal Health; BD; ConvaTec.
b. Key factors that are driving the market growth include increasing prevalence of urinary incontinence, growing geriatric population, and rising incidence of neurogenic bladder.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."